Tavaborole - NDC Database

12 records found

Page:1

0574-0157 Jan 10, 2021
Tavaborole 43.5 mg/ml Topical Solution by Paddock Laboratories, LLC.

21922-020 Oct 19, 2020
Tavaborole 43.5 mg/ml Topical Solution by Encube Ethicals Private Limited

51672-1397 May 07, 2021
Tavaborole 43.5 mg/ml Topical Solution by Taro Pharmaceuticals U.S.a., Inc.

51862-690 Feb 01, 2021
Tavaborole 43.5 mg/ml Topical Solution by Mayne Pharma Inc.

62135-663 Feb 03, 2021
Tavaborole 43.5 mg/ml Topical Solution by Chartwell Rx, LLC

62332-467 Oct 23, 2020
Tavaborole 43.5 mg/ml Topical Solution by Alembic Pharmaceuticals, Inc.

63629-8704 Jan 10, 2021
Tavaborole 43.5 mg/ml Topical Solution by Bryant Ranch Prepack

68180-958 Jul 09, 2021
Tavaborole 43.5 mg/ml Topical Solution by Lupin Pharmaceuticals, Inc.

69097-686 Feb 18, 2021
Tavaborole 43.5 mg/ml Topical Solution by Cipla USA Inc.

69238-1657 Nov 28, 2020
Tavaborole 43.5 mg/ml Topical Solution by Amneal Pharmaceuticals Ny LLC

70771-1826 Apr 24, 2023
Tavaborole 43.5 mg/ml Topical Solution by Zydus Lifesciences Limited

72578-102 Apr 24, 2023
Tavaborole 43.5 mg/ml Topical Solution by Viona Pharmaceuticals Inc

Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.